AEs / PET / 4Astex Therapeutics Limited / Astex Therapeutics Limited. / N B S a / Dana / /
Country
United States / United Kingdom / /
Event
FDA Phase / /
Facility
General Hospital / INTRODUCTION Farber Cancer Institute / Israel Deaconess Medical Center / /
Holiday
between Day / /
IndustryTerm
imaging / /
MedicalCondition
light-headedness / tumor / Squamous cell carcinoma / lymphoma / disease / NSCLC / Glioblastoma Multiforme / metastatic solid tumors / Neutropenia / nausea / Thrombocytopenia / Carcinoma / fever / Colon Cancer / vomiting / melanoma / fatigue / Synovial sarcoma / diarrhea / Refractory Solid Tumors / Prostate Cancer / thyroid cancer / Breast cancer / Rectal cancer / Pancreatic cancer / Hypotension / /
OperatingSystem
Dos / /
Organization
2Massachusetts General Hospital / Harvard / American Society / Yule4 1Dana INTRODUCTION Farber Cancer Institute / 3Beth Israel Deaconess Medical Center / / /
# 3069 Heat Shock Protein 90 Inhibitor in Patients With Refractory Solid Tumors: A Phase I Pharmacokinetic And Pharmacodynamic Study Of AT13387 G I Shapiro1, E L Kwak2, B Dezube3, D P Lawrence2, J M Cleary1, S Lewis4, M